Showing 1 - 9 results of 9 for search 'Jiawen Bu', query time: 0.08s
Refine Results
-
1
Targeting KK-LC-1 inhibits malignant biological behaviors of triple-negative breast cancer by Xudong Zhu, Jiawen Bu, Tong zhu, Yi Jiang
Published 2023-03-01
Article -
2
-
3
Extracellular vesicles in the treatment and diagnosis of breast cancer: a status update by Xiaoying Zhang, Caizheng Wang, Jiahui Yu, Jiawen Bu, Fulv Ai, Yue Wang, Jie Lin, Xudong Zhu
Published 2023-07-01
Article -
4
Advances in immunotherapy for triple-negative breast cancer by Yang Liu, Yueting Hu, Jinqi Xue, Jingying Li, Jiang Yi, Jiawen Bu, Zhenyong Zhang, Peng Qiu, Xi Gu
Published 2023-09-01
Article -
5
Correction: Advances in immunotherapy for triple-negative breast cancer by Yang Liu, Yueting Hu, Jinqi Xue, Jingying Li, Jiang Yi, Jiawen Bu, Zhenyong Zhang, Peng Qiu, Xi Gu
Published 2023-09-01
Article -
6
Dalpiciclib partially abrogates ER signaling activation induced by pyrotinib in HER2+HR+ breast cancer by Jiawen Bu, Yixiao Zhang, Nan Niu, Kewei Bi, Lisha Sun, Xinbo Qiao, Yimin Wang, Yinan Zhang, Xiaofan Jiang, Dan Wang, Qingtian Ma, Huajun Li, Caigang Liu
Published 2023-01-01
Article -
7
KCNJ15 deficiency promotes drug resistance via affecting the function of lysosomes by Xinbo Qiao, Yixiao Zhang, Zhan Zhang, Nan Niu, Haonan Li, Lisha Sun, Qingtian Ma, Jiawen Bu, Jinchi Liu, Guanglei Chen, Jinqi Xue, Yongliang Yang, Caigang Liu
Published 2023-05-01
Article -
8
KK-LC-1 as a therapeutic target to eliminate ALDH+ stem cells in triple negative breast cancer by Jiawen Bu, Yixiao Zhang, Sijin Wu, Haonan Li, Lisha Sun, Yang Liu, Xudong Zhu, Xinbo Qiao, Qingtian Ma, Chao Liu, Nan Niu, Jinqi Xue, Guanglei Chen, Yongliang Yang, Caigang Liu
Published 2023-05-01
Article -
9
Targeting SOST using a small-molecule compound retards breast cancer bone metastasis by Lisha Sun, Yixiao Zhang, Guanglei Chen, Yaoting Ji, Qingtian Ma, Xinbo Qiao, Sijin Wu, Lin Zhou, Jiawen Bu, Xudong Zhu, Xiaoying Zhang, Xiaofan Jiang, Chao Liu, Xinnan Li, Yang Liu, Yongliang Yang, Caigang Liu
Published 2022-12-01
Article